DP117 | THE TREATMENT OF TRANSPLANT ELIGIBLE PRIMARY PLASMA CELL LEUKEMIA PATIENTS: AN ITALIAN REAL-LIFE STUDY

Primary plasma cell leukemia (pPCL) is a rare variant of plasma cell malignancy characterized by at least 5% circulating plasma cell (cPC), aggressive behavior and ominous prognosis. Though to the rarity of the disease, the choice of treatment is most based on real world evidence and expert consens...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	G. Barilà, L. Pavan, F. Fazio, C. Liberatore, N. Sgherza, S. Morè, G. Vianello, C. S. Cartia, S. Oliva, M. Gentile, A. Furlan, M. Arangio Febbo, O. Annibali, L. Pettine, B. Rossini, F. Guidotti, S. Vedovato, F. Rezzonico, R. Della Pepa, P. Boggione, D. Derudas, D. Nappi, F. Farina, F. Vassallo, B. Gamberi, S. Mangiacavalli, N. Giuliani, M. Galli, A. Tosetto, E. Zamagni, F. Patriarca, M. Offidani, M. T. Petrucci, R. Zambello, P. Musto
Format:	Artigo
Sprog:	Inglês
Udgivet:	Ferrata Storti Foundation 2025-09-01
Serier:	Haematologica
Online adgang:	https://haematologica.org/article/view/12614
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!